Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -811.95 M

Albemarle Corporation EBITDA is USD -811.95 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 69.16% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -480.00 M, a -112.88% change year over year.
  • Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 3.73 B, a 1,787.75% change year over year.
  • Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 197.47 M, a -73.54% change year over year.
  • Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 746.38 M, a -16.07% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)